Log in to save to my catalogue

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of no...

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of no...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_650b58462e0a46c6a4a982d979b2522c

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

About this item

Full title

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

Publisher

England: BioMed Central Ltd

Journal title

Journal for immunotherapy of cancer, 2018-07, Vol.6 (1), p.75-75, Article 75

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Lung cancer is the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for over 85% of all cases. Until recently, chemotherapy - characterized by some benefit but only rare durable responses - was the only treatment option for patients with NSCLC whose tumors lacked targetable mutations. By contra...

Alternative Titles

Full title

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_650b58462e0a46c6a4a982d979b2522c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_650b58462e0a46c6a4a982d979b2522c

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1186/s40425-018-0382-2

How to access this item